Position in HLN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$149,513
+$32,837 QoQ
Shares Held
16,025
+37.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#329
of 640 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AlphaCore Capital LLC holds $3,850,142 across 6 Drug Manufacturers - Specialty & Generic names. HLN ranks #6 (3.9% of the industry book) .
All Filings in HLN
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $149,513 | 16,025 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $116,676 | 11,656 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $356,428 | 35,255 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $418,136 | 46,615 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $274,846 | 26,504 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $207,652 | 20,180 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $197,640 | 20,717 | Shares | Sole | 2025-02-21 | |
| 2024-09-30 | $219,185 | 20,717 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $171,122 | 20,717 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $173,340 | 20,417 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $168,031 | 20,417 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $170,073 | 20,417 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $171,094 | 20,417 | Shares | Sole | 2023-08-10 | |
| No filing history on record for this holder in this stock. | ||||||